Sort   by:  
 Page size 
Entry into mitosis is triggered by mitotic kinases that phosphorylate multiple proteins to induce profound cellular changes including nuclear envelope breakdown, chromosome condensation and spindle assembly. Conversely, mitotic exit requires protein dephosphorylation as cells return to their interph...
ORGANISM(S): Drosophila melanogaster (Fruit fly) 
2023-08-10 | PXD041032 | Pride
Entry into mitosis is triggered by mitotic kinases that phosphorylate multiple proteins to induce profound cellular changes including nuclear envelope breakdown, chromosome condensation and spindle assembly. Conversely, mitotic exit requires protein dephosphorylation as cells return to their interph...
ORGANISM(S): Drosophila melanogaster (Fruit fly) 
2023-08-10 | PXD041030 | Pride
Entry into mitosis is triggered by mitotic kinases that phosphorylate multiple proteins to induce profound cellular changes including nuclear envelope breakdown, chromosome condensation and spindle assembly. Conversely, mitotic exit requires protein dephosphorylation as cells return to their interph...
ORGANISM(S): Drosophila melanogaster (Fruit fly) 
2023-08-10 | PXD041091 | Pride
Endogenous retroelements (ERE) constitute about 42% of the human genome and have been implicated in common human diseases such as autoimmunity and cancer. Despite evidence that some EREs can be expressed at the RNA and protein levels in specific contexts, a systems-level evaluation of their expressi...
ORGANISM(S): Homo sapiens (Human) 
2020-05-26 | PXD018124 | Pride
While immune checkpoint blockade (ICB) therapy has significantly improved the outcome of metastatic melanoma and non-small cell lung cancer (NSCLC), most patients do not derive long-term benefits. Previous studies suggest that treatment failure is partly due to insufficient immune recognition of tum...
ORGANISM(S): Homo sapiens (Human) 
2025-02-19 | PXD043059 | Pride
While immune checkpoint blockade (ICB) therapy has significantly improved the outcome of metastatic melanoma and non-small cell lung cancer (NSCLC), most patients do not derive long-term benefits. Previous studies suggest that treatment failure is partly due to insufficient immune recognition of tum...
ORGANISM(S): Homo sapiens (Human) 
2025-02-19 | PXD043057 | Pride
Sort   by:  
 Page size